Experience
  • Secured win for Colovore LLC in litigation concerning data center lease
  • Defended Dr. Hing Wong in arbitration alleging misappropriation of trade secrets relating to innovative cancer treatments
  • Won arbitration for venture firm Lux Capital in M&A dispute
  • Represented Phase Bio in adversary proceeding regarding biotech license agreement
  • Secured win for Odyssey Marine in NAFTA arbitration against Mexico concerning phosphate exploration
  • Represented opioid creditors of Mallinckrodt in bankruptcy proceedings
  • Represented SRS as shareholder representative of selling shareholders of biotech firm Kolltan in milestone dispute against Celldex
  • Successfully defended pharmaceutical company Retrophin (now Travere Therapeutics) in orphan drug antitrust litigation brought by generic competitor
  • Secured arbitration win for Golden Gate Yacht Club against Emirates Team New Zealand over the venue for the America’s Cup
  • Represented a major financial institution in defense of fraud claims by a hedge fund relating to collateralized debt obligations
  • Represented a major financial institution in defense of fraud claims by a foreign bank relating to collateralized debt obligations
  • Secured trial win for Starr International against AIG regarding ownership of $4 billion of AIG stock
  • Represented American Express in antitrust litigation against Visa and Mastercard resulting in record-breaking settlement
Bio

Phil is a first-chair trial lawyer with more than two decades of experience trying cases in federal and state courts across the United States, as well as in domestic and international arbitrations. He represents companies across a wide range of sectors in high-stakes commercial disputes.

He litigates disputes for life sciences and technology companies arising from complex commercial relationships and intellectual property agreements. Phil also handles a broad range of post-acquisition disputes, representing clients in litigation involving mergers and acquisitions, including milestone, earnout, and other contingent payment disagreements.

In addition, he has significant experience litigating trade secret, intellectual property, and restrictive covenant matters, including claims involving the misappropriation of proprietary information, employee noncompete and non-solicitation agreements, and related business disputes.

Phil also represents plaintiffs and defendants in antitrust litigation and advises companies on antitrust issues arising in the M&A context.

His practice further includes representing private equity and venture capital firms, as well as privately held companies, in disputes relating to investments, corporate governance, partnerships, and the management of portfolio companies.

Explore King & Spalding
a blue and green background
Capabilities
Commercial Litigation
Capabilities
Financial Services Litigation
a blue and green background